Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Blocking PD1/PDL1 Interactions Together with MLN4924 Therapy is a Potential Strategy for Glioma Treatment.

Filippova N, Yang X, An Z, Nabors LB, Pereboeva L.

J Cancer Sci Ther. 2018;10(8):190-197. doi: 10.4172/1948-5956.1000543. Epub 2018 Aug 6.

2.

Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia.

Minagawa K, Jamil MO, Al-Obaidi M, Pereboeva L, Salzman D, Erba HP, Lamb LS, Bhatia R, Mineishi S, Di Stasi A.

PLoS One. 2017 Feb 15;12(2):e0172640. doi: 10.1371/journal.pone.0172640. eCollection 2017.

3.

Pulmonary complications post hematopoietic stem cell transplant in dyskeratosis congenita: analysis of oxidative stress in lung fibroblasts.

Sorge C, Pereboeva L, Westin E, Harris WT, Kelly DR, Goldman F.

Bone Marrow Transplant. 2017 May;52(5):765-768. doi: 10.1038/bmt.2016.353. Epub 2017 Jan 16. No abstract available.

PMID:
28092351
4.

In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia.

Minagawa K, Jamil MO, Al-Obaidi M, Pereboeva L, Salzman D, Erba HP, Lamb LS, Bhatia R, Mineishi S, Di Stasi A.

PLoS One. 2016 Dec 1;11(12):e0166891. doi: 10.1371/journal.pone.0166891. eCollection 2016. Erratum in: PLoS One. 2017 Feb 15;12 (2):e0172640.

5.

Effect of HSV-IL12 Loaded Tumor Cell-Based Vaccination in a Mouse Model of High-Grade Neuroblastoma.

Bauer DF, Pereboeva L, Gillespie GY, Cloud GA, Elzafarany O, Langford C, Markert JM, Lamb LS Jr.

J Immunol Res. 2016;2016:2568125. doi: 10.1155/2016/2568125. Epub 2016 Aug 17.

6.

Robust DNA Damage Response and Elevated Reactive Oxygen Species in TINF2-Mutated Dyskeratosis Congenita Cells.

Pereboeva L, Hubbard M, Goldman FD, Westin ER.

PLoS One. 2016 Feb 9;11(2):e0148793. doi: 10.1371/journal.pone.0148793. eCollection 2016.

7.

The safety of allogeneic innate lymphocyte therapy for glioma patients with prior cranial irradiation.

Pereboeva L, Harkins L, Wong S, Lamb LS.

Cancer Immunol Immunother. 2015 May;64(5):551-62. doi: 10.1007/s00262-015-1662-z. Epub 2015 Feb 13.

PMID:
25676710
8.

DNA damage responses and oxidative stress in dyskeratosis congenita.

Pereboeva L, Westin E, Patel T, Flaniken I, Lamb L, Klingelhutz A, Goldman F.

PLoS One. 2013 Oct 4;8(10):e76473. doi: 10.1371/journal.pone.0076473. eCollection 2013.

9.

A myeloid cell-binding adenovirus efficiently targets gene transfer to the lung and escapes liver tropism.

Alberti MO, Deshane JS, Chaplin DD, Pereboeva L, Curiel DT, Roth JC.

Gene Ther. 2013 Jul;20(7):733-41. doi: 10.1038/gt.2012.91. Epub 2012 Nov 22.

10.

Derivation of a myeloid cell-binding adenovirus for gene therapy of inflammation.

Alberti MO, Roth JC, Ismail M, Tsuruta Y, Abraham E, Pereboeva L, Gerson SL, Curiel DT.

PLoS One. 2012;7(5):e37812. doi: 10.1371/journal.pone.0037812. Epub 2012 May 18.

11.

Functional Sindbis virus replicative complexes are formed at the plasma membrane.

Frolova EI, Gorchakov R, Pereboeva L, Atasheva S, Frolov I.

J Virol. 2010 Nov;84(22):11679-95. doi: 10.1128/JVI.01441-10. Epub 2010 Sep 8.

12.

Targeting of mesenchymal stem cells to ovarian tumors via an artificial receptor.

Komarova S, Roth J, Alvarez R, Curiel DT, Pereboeva L.

J Ovarian Res. 2010 May 25;3:12. doi: 10.1186/1757-2215-3-12.

13.

A fiber-modified mesothelin promoter-based conditionally replicating adenovirus for treatment of ovarian cancer.

Tsuruta Y, Pereboeva L, Breidenbach M, Rein DT, Wang M, Alvarez RD, Siegal GP, Dent P, Fisher PB, Curiel DT.

Clin Cancer Res. 2008 Jun 1;14(11):3582-8. doi: 10.1158/1078-0432.CCR-07-5053.

14.

Cell vehicle targeting strategies.

Roth JC, Curiel DT, Pereboeva L.

Gene Ther. 2008 May;15(10):716-29. doi: 10.1038/gt.2008.38. Epub 2008 Mar 27. Review.

PMID:
18369326
15.

An adenoviral platform for selective self-assembly and targeted delivery of nanoparticles.

Saini V, Martyshkin DV, Mirov SB, Perez A, Perkins G, Ellisman MH, Towner VD, Wu H, Pereboeva L, Borovjagin A, Curiel DT, Everts M.

Small. 2008 Feb;4(2):262-9. doi: 10.1002/smll.200700403.

PMID:
18200644
16.

Adenovirus tumor targeting and hepatic untargeting by a coxsackie/adenovirus receptor ectodomain anti-carcinoembryonic antigen bispecific adapter.

Li HJ, Everts M, Pereboeva L, Komarova S, Idan A, Curiel DT, Herschman HR.

Cancer Res. 2007 Jun 1;67(11):5354-61.

17.

A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway.

Tsuruta Y, Pereboeva L, Glasgow JN, Rein DT, Kawakami Y, Alvarez RD, Rocconi RP, Siegal GP, Dent P, Fisher PB, Curiel DT.

Clin Cancer Res. 2007 May 1;13(9):2777-83.

18.

Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus.

Pereboeva L, Komarova S, Roth J, Ponnazhagan S, Curiel DT.

Gene Ther. 2007 Apr;14(8):627-37. Epub 2007 Jan 25.

19.

Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma.

Stoff-Khalili MA, Rivera AA, Mathis JM, Banerjee NS, Moon AS, Hess A, Rocconi RP, Numnum TM, Everts M, Chow LT, Douglas JT, Siegal GP, Zhu ZB, Bender HG, Dall P, Stoff A, Pereboeva L, Curiel DT.

Breast Cancer Res Treat. 2007 Oct;105(2):157-67. Epub 2007 Jan 13.

PMID:
17221158
20.

Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses.

Komarova S, Kawakami Y, Stoff-Khalili MA, Curiel DT, Pereboeva L.

Mol Cancer Ther. 2006 Mar;5(3):755-66.

21.

Reovirus sigma1 fiber incorporated into adenovirus serotype 5 enhances infectivity via a CAR-independent pathway.

Tsuruta Y, Pereboeva L, Glasgow JN, Luongo CL, Komarova S, Kawakami Y, Curiel DT.

Biochem Biophys Res Commun. 2005 Sep 16;335(1):205-14.

PMID:
16061208
22.

A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.

Stoff-Khalili MA, Rivera AA, Glasgow JN, Le LP, Stoff A, Everts M, Tsuruta Y, Kawakami Y, Bauerschmitz GJ, Mathis JM, Pereboeva L, Seigal GP, Dall P, Curiel DT.

Gene Ther. 2005 Dec;12(23):1696-706.

PMID:
16034451
23.

Cellular vehicles for cancer gene therapy: current status and future potential.

Pereboeva L, Curiel DT.

BioDrugs. 2004;18(6):361-85. Review.

PMID:
15571421
24.

Fiber-mosaic adenovirus as a novel approach to design genetically modified adenoviral vectors.

Pereboeva L, Komarova S, Mahasreshti PJ, Curiel DT.

Virus Res. 2004 Sep 15;105(1):35-46.

PMID:
15325079
25.

Approaches to utilize mesenchymal progenitor cells as cellular vehicles.

Pereboeva L, Komarova S, Mikheeva G, Krasnykh V, Curiel DT.

Stem Cells. 2003;21(4):389-404.

26.
27.

Hepatitis C epitopes from phage-displayed cDNA libraries and improved diagnosis with a chimeric antigen.

Pereboeva LA, Pereboev AV, Wang LF, Morris GE.

J Med Virol. 2000 Feb;60(2):144-51.

PMID:
10596013
28.

Identification of antigenic sites on three hepatitis C virus proteins using phage-displayed peptide libraries.

Pereboeva LA, Pereboev AV, Morris GE.

J Med Virol. 1998 Oct;56(2):105-11.

PMID:
9746064
29.

[Constructing the reference panel of sera with standard level of IgG-antibodies].

Kanev AN, Vorob'eva MS, Shalunova NV, Pereboeva LA, Maksiutov AZ, Kiselev NN, Shalaev EIu, Iastrebova ON, Varaksin NA.

Vopr Virusol. 1996 Jul-Aug;41(4):161-6. Russian.

PMID:
8999670
30.

Ebola virus infection in guinea pigs: presumable role of granulomatous inflammation in pathogenesis.

Ryabchikova E, Kolesnikova L, Smolina M, Tkachev V, Pereboeva L, Baranova S, Grazhdantseva A, Rassadkin Y.

Arch Virol. 1996;141(5):909-21.

PMID:
8678836
31.

[Experimental study of the possibility of emergency prophylaxis of Bolivian hemorrhagic fever].

Kaliberov SA, Ignat'ev GM, Pereboeva LA, Kashentseva EA.

Vopr Virusol. 1995 Sep-Oct;40(5):211-5. Russian.

PMID:
8659175
32.

[Study of the immunobiological properties of parotitis viral strains].

Agafonov AP, Kaliberov SA, Patrusheva IV, Nicheukhina SN, Pereboeva LA, Ignat'ev GM.

Vopr Virusol. 1995 May-Jun;40(3):115-9. Russian.

PMID:
7676672
33.

[Study of certain indicators of immunity upon infecting CBA/Calac line mice with Lassa virus].

Ignat'ev GM, Kaliberov SA, Pereboeva LA, Tverdokhlebov AB, Kras'ko AG, Godneva AT.

Vopr Virusol. 1994 Nov-Dec;39(6):257-60. Russian.

PMID:
7536373
34.

[The ultrastructural changes in guinea pig organs during the serial passage of the Ebola virus].

Pereboeva LA, Tkachev VK, Kolesnikova LV, Krendeleva LIa, Riabchikova EI, Smolina MP.

Vopr Virusol. 1993 Jul-Aug;38(4):179-82. Russian.

PMID:
8236945
35.

[The immunity indices in the infection of mice of different strains with the Machupo virus].

Ignat'ev GM, Tverdokhlebov AV, Kaliberov SA, Pereboeva LA, Patrusheva IV, Kashentseva EA.

Vopr Virusol. 1993 Jul-Aug;38(4):167-70. Russian.

PMID:
8236941
36.

[Effect of lipid peroxidation on the insulin receptor in rat adipocytes].

Ivanov VV, Stennikova MP, Pereboeva LA, Udintsev NA.

Ukr Biokhim Zh (1978). 1987 Mar-Apr;59(2):57-61. Russian.

PMID:
3554677

Supplemental Content

Loading ...
Support Center